ABBV vs GSK: Which Is the Better Dividend Stock?
As of September 2026, ABBV (AbbVie Inc.) screens as the stronger dividend stock, winning 5 of 8 head-to-head metrics. GSK offers the higher yield at 3.62%, ABBV has the higher dividend-safety score, and GSK trades at the larger discount to fair value (+9%).
| Metric | ABBV | GSK |
|---|---|---|
| Forward yield | 2.62% | 3.62% |
| Annual dividend | $6.92 | $1.82 |
| Payout ratio | 190% | 57% |
| Years of growth | 12 yr | 2 yr |
| 5-yr dividend growth | 6.8% | -4.0% |
| 5-yr total return | 130% | 19% |
| Dividend safety score | 80 (A) | 55 (C) |
| Fair value estimate | $221.69 | $54.84 |
| Upside to fair value | -16% | +9% |
| Frequency | quarterly | quarterly |
| Market cap | $466.4B | $100.6B |
| P/E ratio | 74.6 | 15.9 |
Higher yield
GSK
3.62%
Safer dividend
ABBV
Grade A
Faster growth
ABBV
6.8%
Better value
GSK
+9% upside
ABBV vs GSK — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.